The Food and Drug Administration (FDA) has approved the first pill to treat postpartum depression (PPD), the agency announced Friday. Zurzuvae is the market’s first pill medication for the disorder that can occur, in mild cases, in as many as 50 percent of new mothers. “Postpartum depression is a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness — even, in severe cases, thoughts of harming themselves or their child,” FDA Director of Psychiatry Tiffany Farchione said in a statement. “Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, fe
Hence then, the article about fda approves first pill to help treat postpartum depression was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA approves first pill to help treat postpartum depression )